{
    "clinical_study": {
        "@rank": "90990", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die. Combining more than one drug may kill more tumor cells.\n\n      PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating\n      patients who have stage IC, stage IIB, stage III, or stage IV ovarian epithelial, fallopian\n      tube, or peritoneal cancer that has not been previously treated."
        }, 
        "brief_title": "Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer", 
        "condition": [
            "Fallopian Tube Cancer", 
            "Ovarian Cancer", 
            "Primary Peritoneal Cavity Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Ovarian Neoplasms", 
                "Peritoneal Neoplasms", 
                "Fallopian Tube Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the tolerability and toxicity of paclitaxel, carboplatin, and gemcitabine in\n           patients with previously untreated stage IC-IV ovarian epithelial, fallopian tube, or\n           peritoneal carcinoma.\n\n        -  Determine the response rate of patients treated with this regimen.\n\n        -  Determine the time to progression and overall survival of patients treated with this\n           regimen.\n\n      OUTLINE: This is a multicenter study.\n\n      Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30 minutes on day 1 and\n      gemcitabine IV over 30-60 minutes on days 1 and 8. Treatment repeats every 3 weeks in the\n      absence of disease progression or unacceptable toxicity.\n\n      Patients are followed at 3 and 6 months.\n\n      PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically confirmed stage IC-IV ovarian epithelial, fallopian tube, or\n             peritoneal carcinoma\n\n               -  No tumors of low-malignant potential (borderline tumors)\n\n          -  No symptomatic brain metastases\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  18 and over\n\n        Performance status:\n\n          -  ECOG 0-2 OR\n\n          -  Karnofsky 70-100%\n\n        Life expectancy:\n\n          -  At least 6 months\n\n        Hematopoietic:\n\n          -  WBC at least 3,000/mm^3\n\n          -  Absolute neutrophil count at least 1,500/mm^3\n\n          -  Platelet count at least 100,000/mm^3\n\n          -  Hemoglobin greater than 10 g/dL\n\n        Hepatic:\n\n          -  Bilirubin no greater than 2 times upper limit of normal\n\n        Renal:\n\n          -  Glomerular filtration rate at least 60 mL/min\n\n        Cardiovascular:\n\n          -  No history of congestive heart failure (New York Heart Association class III or IV\n             heart disease) even if medically controlled\n\n          -  No myocardial infarction within the past 6 months\n\n          -  No history of atrial or ventricular arrhythmias\n\n        Neurologic:\n\n          -  No history of seizure disorder\n\n          -  No history of CNS disorder\n\n          -  No pre-existing motor or sensory neuropathy or symptoms grade 2 or greater\n\n        Other:\n\n          -  No severe concurrent infection\n\n          -  No prior hypersensitivity reaction to products containing Cremophor EL or compounds\n             chemically related to carboplatin, paclitaxel, or gemcitabine\n\n          -  No complete bowel obstruction\n\n          -  No other concurrent severe medical problems that would preclude study\n\n          -  Not pregnant or nursing\n\n          -  Negative pregnancy test\n\n          -  Fertile patients must use effective contraception\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  No concurrent immunotherapy\n\n          -  No concurrent WBC transfusions\n\n        Chemotherapy:\n\n          -  No prior chemotherapy\n\n          -  No other concurrent chemotherapy\n\n        Endocrine therapy:\n\n          -  No concurrent hormonal therapy except replacement therapy or steroid antiemetics\n\n        Radiotherapy:\n\n          -  No prior radiotherapy\n\n          -  No concurrent radiotherapy\n\n        Surgery:\n\n          -  No more than 6 weeks since prior definitive surgery"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "105", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 8, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00031954", 
            "org_study_id": "CDR0000069242", 
            "secondary_id": [
                "AGOSG-OVAR-8", 
                "EU-20146"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "carboplatin", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "gemcitabine hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "paclitaxel", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Gemcitabine", 
                "Carboplatin", 
                "Paclitaxel"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "stage II ovarian epithelial cancer", 
            "stage I ovarian epithelial cancer", 
            "stage III ovarian epithelial cancer", 
            "stage IV ovarian epithelial cancer", 
            "fallopian tube cancer", 
            "primary peritoneal cavity cancer"
        ], 
        "lastchanged_date": "June 28, 2012", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/AGOSG-OVAR-8"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "D-10117"
                    }, 
                    "name": "Universitaetsklinikum Charite"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bremen", 
                        "country": "Germany", 
                        "zip": "D-28205"
                    }, 
                    "name": "Zentralkrankenhaus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dresden", 
                        "country": "Germany", 
                        "zip": "D-01307"
                    }, 
                    "name": "Medizinische Klinik I"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dusseldorf", 
                        "country": "Germany", 
                        "zip": "DOH-4-0217"
                    }, 
                    "name": "Evangelisches Krankenhaus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankfurt", 
                        "country": "Germany", 
                        "zip": "D-60590"
                    }, 
                    "name": "Klinikum der J.W. Goethe Universitaet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankfurt Am Main", 
                        "country": "Germany", 
                        "zip": "65929"
                    }, 
                    "name": "Staedtisches Krankenhaus FFM-Hoechst"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gottingen", 
                        "country": "Germany", 
                        "zip": "D-37075"
                    }, 
                    "name": "Universitaetsklinik Goettingen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greifswald", 
                        "country": "Germany", 
                        "zip": "D-17487"
                    }, 
                    "name": "Klinik Fuer Innere Medizin Hematology/Oncology, Ernst Moritz Armdt Universitaet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "zip": "30659"
                    }, 
                    "name": "Frauenklinik der MHH"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Karlsruhe", 
                        "country": "Germany", 
                        "zip": "D-76137"
                    }, 
                    "name": "Vincentius Krankenhaus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kiel", 
                        "country": "Germany", 
                        "zip": "D-24105"
                    }, 
                    "name": "Christian-Albrechts University of Kiel"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Magdeburg", 
                        "country": "Germany", 
                        "zip": "39108"
                    }, 
                    "name": "Klinik der Otto-v.-Guericke-Universitat"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Muenster", 
                        "country": "Germany", 
                        "zip": "D-48129"
                    }, 
                    "name": "Klinik und Poliklinik fuer Kinderheilkunde"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Munich (Muenchen)", 
                        "country": "Germany", 
                        "zip": "D-81377"
                    }, 
                    "name": "Klinikum Grosshadern"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Munich (Muenchen)", 
                        "country": "Germany", 
                        "zip": "D-81675"
                    }, 
                    "name": "Klinikum Rechts Der Isar/Technische Universitaet Muenchen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tuebingen", 
                        "country": "Germany", 
                        "zip": "D-72076"
                    }, 
                    "name": "Universitaetsklinikum Tuebingen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ulm", 
                        "country": "Germany", 
                        "zip": "D-89075"
                    }, 
                    "name": "Universitaet Ulm"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wiesbaden", 
                        "country": "Germany", 
                        "zip": "D-65199"
                    }, 
                    "name": "Dr. Horst-Schmidt-Kliniken"
                }
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase II Study Of Paclitaxel, Carboplatin And Gemcitabine In Previously Untreated Patients With Epithelial Ovarian Carcinoma FIGO Stage IIB-IV", 
        "overall_official": {
            "affiliation": "Dr. Horst-Schmidt-Kliniken", 
            "last_name": "Andreas du Bois, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2004", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The decision level is reached, when the lower exact 95% confidence limit of the observed proportion is higher than the upper exact 95% confidence limit of the historical proportion, which corresponds to a power of 0.5 applying a significance level of 0.05", 
            "measure": "Evaluation of tolerability and toxicity of the combination therapy with paclitaxel, carboplatin and gemcitabine (P-C-G) in first line treatment of ovarian cancer patients. Evaluation of Drop-out rate due to toxicity", 
            "safety_issue": "Yes", 
            "time_frame": "Based on decision level"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00031954"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "15661234", 
            "citation": "du Bois A, Belau A, Wagner U, Pfisterer J, Schmalfeldt B, Richter B, Staehle A, Jackisch C, Lueck HJ, Schroeder W, Burges A, Olbricht S, Elser G; for the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC-IV (AGO-OVAR protocol OVAR-8). Gynecol Oncol. 2005 Feb;96(2):444-51."
        }, 
        "source": "AGO Study Group", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AGO Study Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2001", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2012"
    }, 
    "geocoordinates": {
        "Christian-Albrechts University of Kiel": "54.323 10.123", 
        "Dr. Horst-Schmidt-Kliniken": "50.063 8.243", 
        "Evangelisches Krankenhaus": "51.221 6.81", 
        "Frauenklinik der MHH": "52.384 9.727", 
        "Klinik Fuer Innere Medizin Hematology/Oncology, Ernst Moritz Armdt Universitaet": "54.087 13.392", 
        "Klinik der Otto-v.-Guericke-Universitat": "52.131 11.629", 
        "Klinik und Poliklinik fuer Kinderheilkunde": "51.951 7.626", 
        "Klinikum Grosshadern": "48.145 11.558", 
        "Klinikum Rechts Der Isar/Technische Universitaet Muenchen": "48.145 11.558", 
        "Klinikum der J.W. Goethe Universitaet": "50.111 8.682", 
        "Medizinische Klinik I": "51.031 13.757", 
        "Staedtisches Krankenhaus FFM-Hoechst": "50.111 8.682", 
        "Universitaet Ulm": "48.404 9.979", 
        "Universitaetsklinik Goettingen": "51.538 9.93", 
        "Universitaetsklinikum Charite": "52.524 13.406", 
        "Universitaetsklinikum Tuebingen": "48.521 9.059", 
        "Vincentius Krankenhaus": "49.009 8.38", 
        "Zentralkrankenhaus": "53.085 8.821"
    }
}